Analyst
Needham
Equibles does not estimate personal net worth.
Mike Mattson is recorded as Analyst at Needham. Mike Mattson has spoken on 17 earnings calls and 2 other investor events across 12 companies, most recently for LivaNova PLC on August 5, 2026. Those appearances were for Insight Molecular Diagnostics Inc. (IMDX), Teleflex Inc (TFX), LivaNova PLC (LIVN), Neogenomics Inc (NEO), AtriCure, Inc. (ATRC) and 7 other companies. The companies whose calls Mike Mattson spoke on are classified in the Healthcare sector.
“So just a few questions on the oxygenator business. So with the new Oxygenator that you're developing, it sounds like you're going to be kind of producing that at the same time as the prior generation.”
“So good to see the progress with the Medicare coverage of radar.”
“So, just starting with the box NOAF trial, it's great to hear that it's running ahead of expectations in terms of the timing. I guess once the data is available, what's sort of the next step?”
“And then just a couple on the sales, the direct sales force. So where are you hiring the reps from? Are they do they have wound care experience? Do they have other skin substitute experience?”
“So just once you get the FDA clearance, how quickly can you start to drive sales of the kits? And, you know, are there any hurdles you have to cross once you get the FDA clearance in place?”
Needham
Analyst
Transcript header (unverified)
Diagnostics & Research · Healthcare
TFX
Medical Instruments & Supplies · Healthcare
LIVN
Medical Devices · Healthcare
NEO
Diagnostics & Research · Healthcare
ATRC
Medical Instruments & Supplies · Healthcare
CNMD
Medical Devices · Healthcare
ANGO
Medical Instruments & Supplies · Healthcare
INGN
Medical Devices · Healthcare
SYK
Medical Devices · Healthcare
PSNL
Diagnostics & Research · Healthcare
